Autoimmune diseases (e.g., Systemic lupus erythematosus, Malignant rheumatoid arthritis, Guillain-Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Multiple sclerosis)
- Therapeutic plasmapheresis by removing pathogenic substances from patient's plasma by selective adsorption.
- No need for the replacement of plasma, minimizing the risk of infection with hepatitis, AIDS, etc.
- Applicable to patients with protein allergy.
IMMUSORBA is a trademark of Asahi Kasei Medical Co., Ltd.
Please feel free to send us any questions you may have about our products and support.